MarketCap
Facebook
X
TelegramAnnual report 2022
added 08-16-2022
Global Cord Blood Corporation Interest Expense 2011-2025 | CO
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.27 M | 8.16 M | 7.39 M | 5.7 M | 3.26 M | 119 M | 108 M | 101 M | 70.1 M | 70.1 M | 3.29 M | 2.61 M |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 119 M | 2.61 M | 42.1 M |
Quarterly Interest Expense Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 583 K | - | - | - | 1.2 M | - | - | - | 422 K | - | - | - | -56 K | - | - | - | 993 K | - | - | - | 29.8 M | - | - | - | 26.3 M | - | - | - | 25.2 M | - | - | - | 16.5 M | 14.8 M | - | - | 14.1 M | 10.2 M | 896 K | 741 K | 1.19 M | 460 K | 657 K |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 29.8 M | -56 K | 8.46 M |
Interest Expense of other stocks in the Diagnostics research industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
8.42 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
118 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
DarioHealth Corp.
DRIO
|
-31 K | $ 10.33 | 1.87 % | $ 293 M |  Israel |
 |
DexCom
DXCM
|
20.3 M | $ 67.22 | 0.54 % | $ 25.9 B |  USA |
 |
Exact Sciences Corporation
EXAS
|
18.6 M | $ 101.52 | -0.07 % | $ 18.8 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
1.54 M | $ 20.19 | -7.26 % | $ 217 M |  China |
 |
Accelerate Diagnostics
AXDX
|
235 K | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
316 K | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-10.1 M | $ 1.52 | -0.65 % | $ 1.93 M | USA |
 |
Castle Biosciences
CSTL
|
1 K | $ 39.92 | -0.7 % | $ 1.11 B | USA |
 |
Chembio Diagnostics
CEMI
|
2.94 K | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
-56 M | $ 231.15 | 0.14 % | $ 169 B | USA |
 |
Mettler-Toledo International
MTD
|
74.6 M | $ 1 416.97 | 0.17 % | $ 30.1 B |  Schweiz |
 |
Fulgent Genetics
FLGT
|
561 K | $ 27.03 | -0.48 % | $ 817 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-691 K | $ 5.06 | -0.81 % | $ 2.72 M | USA |
 |
NeoGenomics
NEO
|
-379 K | $ 12.23 | -1.57 % | $ 1.55 B | USA |
 |
Neogen Corporation
NEOG
|
38.1 M | $ 7.07 | -1.12 % | $ 1.53 B | USA |
 |
Genetic Technologies Limited
GENE
|
15.2 K | - | - | $ 7.1 B |  Australia |
 |
DermTech
DMTK
|
-355 K | - | -11.32 % | $ 2.94 M | USA |
 |
Pacific Biosciences of California
PACB
|
14.3 M | $ 1.86 | 1.92 % | $ 472 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
288 M | $ 26.95 | 0.26 % | $ 20 B |  Niderland |
 |
CareDx, Inc
CDNA
|
1.34 M | $ 19.68 | -1.7 % | $ 1.06 B | USA |
 |
Celcuity
CELC
|
2.11 M | $ 101.8 | -0.54 % | $ 4.02 B | USA |
 |
Enzo Biochem
ENZ
|
494 K | - | -8.98 % | $ 14.8 K | USA |
 |
Precipio
PRPO
|
-1 K | $ 23.89 | 2.56 % | $ 31 M | USA |
 |
Anixa Biosciences
ANIX
|
500 K | $ 3.38 | 2.42 % | $ 108 K | USA |
 |
QIAGEN N.V.
QGEN
|
-739 K | $ 45.7 | 0.2 % | $ 10.2 B | Niderland |
 |
Co-Diagnostics
CODX
|
106 K | $ 0.24 | -3.06 % | $ 7.04 M | USA |
 |
IQVIA Holdings
IQV
|
670 M | $ 225.46 | 0.14 % | $ 40.9 B | USA |
 |
Guardant Health
GH
|
-42.6 M | $ 102.65 | 0.15 % | $ 12.6 B | USA |
 |
Sotera Health Company
SHC
|
5.31 M | $ 17.6 | 1.06 % | $ 4.98 B | USA |
 |
Aspira Women's Health
AWH
|
106 K | - | -6.19 % | $ 10.5 M | USA |
 |
Soleno Therapeutics
SLNO
|
110 K | $ 49.59 | 1.53 % | $ 1.99 B | USA |
 |
Heska Corporation
HSKA
|
4.19 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
857 K | - | -20.0 % | $ 1.06 M | USA |
 |
Trinity Biotech plc
TRIB
|
6.75 M | $ 1.11 | -13.24 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
-903 K | $ 33.17 | -1.98 % | $ 1.98 B | USA |
 |
Illumina
ILMN
|
-292 M | $ 135.52 | -0.49 % | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
-16.5 M | $ 202.19 | -0.34 % | $ 10.4 B | USA |
 |
Quotient Limited
QTNT
|
2.72 M | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
30 M | $ 175.91 | 0.47 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
8.26 M | $ 6.65 | -1.48 % | $ 862 M | USA |
 |
Myriad Genetics
MYGN
|
1.1 M | $ 6.5 | -0.99 % | $ 589 M | USA |